ARCHIVES

CCIRC Okays New Effort To Rate Disease Committees, Modalities In Groups, Effective with Next Round

This article is from The Cancer Letter archive.

Vol. 07 No. 47 | November 20, 1981

Download PDF Visit The Full Archive

Related Articles

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

DCPC Board Approves Concepts For New Master Agreement, Recompetitions

October 9, 1987

A History of NCCN

January 13, 2012

In Brief: Nutrition Research Intrigues Investigators After All; Advisory Committee Being Formed

March 7, 1975

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

August 11, 1989

Other Concepts Approves By DCE Board Last Week

June 20, 1986